US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward
Executive Summary
System likely will evolve as post-pandemic world unfolds, but adds to list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.
You may also be interested in...
Surprise US FDA Facility Inspections Resume In India
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.
Remote Inspections: Stakeholders Seek Clarity As Some At US FDA Struggle With Process
Some lawmakers want FDA to prioritize in-person visits, but others are complaining that more remote inspections are needed because approvals are being delayed.
How The US FDA’s Inspectional Approach Is Shifting For The Post-Pandemic Era
Agency hints of a “hybrid” future of in-person inspections supplemented by alternative tools like remote interactive evaluations.